BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20926745)

  • 1. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.
    Siu MK; Chan HY; Kong DS; Wong ES; Wong OG; Ngan HY; Tam KF; Zhang H; Li Z; Chan QK; Tsao SW; Strömblad S; Cheung AN
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18622-7. PubMed ID: 20926745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
    Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
    Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
    He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
    Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma.
    Kesanakurti D; Chetty C; Rajasekhar Maddirela D; Gujrati M; Rao JS
    Cell Death Dis; 2012 Dec; 3(12):e445. PubMed ID: 23254288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21-activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1/2 pathway mediated MMP-2 secretion.
    Lu W; Xia YH; Qu JJ; He YY; Li BL; Lu C; Luo X; Wan XP
    Neoplasma; 2013; 60(5):493-503. PubMed ID: 23790167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion.
    Siu MK; Wong ES; Chan HY; Kong DS; Woo NW; Tam KF; Ngan HY; Chan QK; Chan DC; Chan KY; Cheung AN
    Int J Cancer; 2010 Jul; 127(1):21-31. PubMed ID: 19876919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
    Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
    Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell Proliferation.
    Siu MK; Kong DS; Ngai SY; Chan HY; Jiang L; Wong ES; Liu SS; Chan KK; Ngan HY; Cheung AN
    PLoS One; 2015; 10(7):e0133467. PubMed ID: 26218748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
    Zhang L; Lin S; Zhang Z; Yan C; Liu F
    Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression.
    Wang Y; Shao F; Chen L
    Asia Pac J Clin Oncol; 2022 Feb; 18(1):76-83. PubMed ID: 33765367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
    Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
    J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers.
    Siu MK; Wong ES; Kong DS; Chan HY; Jiang L; Wong OG; Lam EW; Chan KK; Ngan HY; Le XF; Cheung AN
    Oncogene; 2013 Jul; 32(30):3500-9. PubMed ID: 22945654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells.
    Thibault B; Jean-Claude B
    J Ovarian Res; 2017 Apr; 10(1):31. PubMed ID: 28446239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer.
    Li J; Huang H; Li Y; Li L; Hou W; You Z
    Oncol Rep; 2016 Dec; 36(6):3241-3250. PubMed ID: 27779700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.
    Li SQ; Wang ZH; Mi XG; Liu L; Tan Y
    IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed PAK4 promotes proliferation, migration and invasion of choriocarcinoma.
    Zhang HJ; Siu MK; Yeung MC; Jiang LL; Mak VC; Ngan HY; Wong OG; Zhang HQ; Cheung AN
    Carcinogenesis; 2011 May; 32(5):765-71. PubMed ID: 21325635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated Pak4 expression correlates with poor prognosis in human gastric cancer patients.
    Li D; Zhang Y; Li Z; Wang X; Qu X; Liu Y
    Tumour Biol; 2015 Dec; 36(12):9431-6. PubMed ID: 26124003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p21-activated kinase 4-Slug transcription factor axis promotes epithelial-mesenchymal transition and worsens prognosis in prostate cancer.
    Park JJ; Park MH; Oh EH; Soung NK; Lee SJ; Jung JK; Lee OJ; Yun SJ; Kim WJ; Shin EY; Kim EG
    Oncogene; 2018 Sep; 37(38):5147-5159. PubMed ID: 29849120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.